The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.20 - Manufacture of pharmaceutical preparations
200 jobs Number of planned job losses
Announcement Date
19 June 2019
Employment effect (start)
Foreseen end date
Description
Sanquin Plasma Products, a daughter company of blood supplier Sanquin, and producer of plasma medicinal products is going through a major reorganisation. Around 200 out of 750 jobs will be cut in 2019. Sanquin Plasma Products experienced serious production issues last year, already leading to concerns about the company’s future. This year it was announced that the biggest client of Sanquin Plasma Products, Shire, is reducing the amount of production it will buy. As a result Sanquin Plasma Products is expected to incur heavy losses in the coming years, however the company plans to counter part of the expected losses with the announced reorganisation.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
